Evidence-Based Complementary and Alternative Medicine / 2015 / Article / Fig 2

Research Article

Gastrodin Reduces Blood Pressure by Intervening with RAAS and PPARγ in SHRs

Figure 2

Effects of 4-week treatment with gastrodin on body weight of rats. Ten-week-old male Wistar-Kyoto (WKY) and spontaneously hypertensive rats (SHRs) were obtained. SHRs were randomly divided into model (SHR) and treatment groups (GAS). WKY belonged to control group (WKY). The first two weeks was adaptation period. Starting from the third week, rats in GAS group were intraperitoneally injected with gastrodin at the dose of 100 mg/(kg⋅d) for 4 weeks. The rest of the rats were not given any intervention other than providing food and water. The body weights were recorded weekly during the experimental period. Values are shown as means ± SEM. versus WKY.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.